Background
==========

Nonalcoholic fatty liver disease (NAFLD) is defined as the pathological accumulation of fat in liver cells and tissues in the absence of hepatotoxicity due to alcohol intake or any other identified cause. NAFLD describes a spectrum of changes in the liver associated with fat accumulation that include simple hepatic steatosis, nonalcoholic steatohepatitis (NASH), fibrosis, and liver cirrhosis \[[@b1-medscimonit-24-6946]\]. The global prevalence of NAFLD has been estimated to be as high as 25.2%, with the Middle East and South America showing the highest prevalence, and Africa has the lowest prevalence \[[@b2-medscimonit-24-6946]\]. In Asia, the prevalence of NAFLD has been reported to have recently increased to 27.4% \[[@b3-medscimonit-24-6946]\]. This high prevalence of NAFLD in Asia might be due to changes in lifestyle and dietary patterns, including the increasing availability of highly calorific convenience foods.

Simple hepatic steatosis is a mild form of NAFLD, which may progress to NASH in some cases. Progression to NASH has been reported in 44% of patients with simple hepatic steatosis at baseline \[[@b4-medscimonit-24-6946]\]. In cases of NASH, up to 2.8% of patients may develop end-stage liver cirrhosis or hepatocellular carcinoma (HCC) \[[@b5-medscimonit-24-6946]\]. Therefore, because the liver changes in NASH can be progressive and irreversible, NASH has become an increasingly common reason for liver transplantation \[[@b4-medscimonit-24-6946]\]. Associations between NAFLD and insulin resistance, obesity, hyperlipidemia, type 2 diabetes, and metabolic syndrome have been shown \[[@b4-medscimonit-24-6946]\]. However, the pathogenesis of NAFLD and the associated phenotypes remain to be elucidated.

The progression of NAFLD to cirrhosis and HCC is variable and modified by age, gender, genetic predisposition, and epigenetic factors. Despite being an invasive procedure associated with some degree of risk and dependency on adequate, relevant liver sampling, liver biopsy remains the gold standard for assessing all form of NAFLD. Optimal non-invasive detection methods for NAFLD are still being developed. However, a new approach for understanding the pathogenesis of NAFLD might be provided by identifying epigenetic modifications \[[@b6-medscimonit-24-6946]\], which are known to be involved in insulin resistance (IR) and to affect lipid metabolism, and the liver cell endoplasmic reticulum and mitochondria due to oxidative stress responses \[[@b7-medscimonit-24-6946]\].

DNA methylation occurs at the cytosine base within cytosine-guanine dinucleotides, which are referred to as CpG sites. During DNA methylation, DNA methyltransferase catalyzes the transfer of a methyl group to the fifth carbon atom from 5-methylcytosine within the cytosine ring, and an increased DNA methylation level of promoters that usually correlates with low or no transcription \[[@b8-medscimonit-24-6946]\]. Also, the hypermethylation of the CpG islands is usually associated with gene silencing, and global hypomethylation of genomic DNA can affect genomic stability \[[@b9-medscimonit-24-6946]\].

There have been few previously published studies on the potential role of DNA methylation in NAFLD. A study using a rodent model showed that diets depleted of methyl donors could promote DNA hypomethylation of important metabolism-related genes and that this hypomethylation altered hepatic fat metabolism, resulting in simple hepatic steatosis \[[@b10-medscimonit-24-6946]\]. Recent research on human liver disease has begun to apply the genome-wide association studies (GWAS) \[[@b11-medscimonit-24-6946],[@b12-medscimonit-24-6946]\], which have shown that alterations in the pattern of DNA methylation are capable of inducing gene expression changes that are reversible and can contribute to insulin resistance and changes in lipid metabolism \[[@b13-medscimonit-24-6946]\]. The use of GWAS means that there is now the potential to detect epigenetic modifiers in NAFLD, which might provide molecular tools for diagnosing, assessing the severity, and predicting disease progression \[[@b14-medscimonit-24-6946]\].

Recently, studies have explored the possibility of using circulating leukocytes, derived from peripheral blood samples, for the evaluation of potential biomarkers in liver disease \[[@b15-medscimonit-24-6946]\]. A recent study by Nano et al., which was the most extensive study to date using circulating leukocytes, identified CpG sites and DNA methylation levels that were associated with serum enzyme levels and simple hepatic steatosis, resulting in new insights into the epigenetic mechanisms associated with NAFLD \[[@b16-medscimonit-24-6946]\].

The aims of the present study were to identify DNA methylation sites in peripheral blood leukocytes in patients with histologically confirmed NAFLD, including simple hepatic steatosis and NASH. Of particular interest was the possibility that epigenetic changes in DNA methylation were associated with clinical parameters, including serum liver enzymes, and lipid profiles, as well as the histological features of NAFLD. The use of routine blood samples was combined with findings from liver biopsy histology, with the aim of determining whether circulating leukocytes could be used to identify specific methylated CpGs that could be related to liver enzyme levels, lipid profiles, or NAFLD phenotypes, to provide novel non-invasive biomarkers for NAFLD, but mainy for NASH in this study.

Material and Methods
====================

Study participants and study design
-----------------------------------

Between March 2012 and May 2013, 35 Chinese Han patients with NAFLD between the ages of 18--70 years were recruited to the study in Shanghai, China. Also, 30 healthy controls with normal liver function tests were recruited. Individuals were excluded from the study if they reported excessive alcohol consumption (\>30 g/day for men; \>20 g/day for women) or had known diseases that could cause fatty liver, such as chronic hepatitis C, autoimmune hepatitis, drug-induced liver injury or Wilson's disease, who were being given total parenteral nutrition (TPN), exhibited other end-stage diseases or malignancy, or who had diabetes mellitus. To ensure patient confidentiality, patient anonymity was included in the study protocol, and to meet the appropriate ethical requirements, all procedures were conducted in accordance with the ethical principles of the Declaration of Helsinki.

Evaluated clinical variables
----------------------------

All clinical variables were evaluated according to the normal reference standards of our institution. Venous blood samples and metabolic profiles were obtained from NAFLD patients and normal controls. The body mass index (BMI) was calculated using the weight (in kilograms) divided by the square of their height (in meters) (kg/m^2^). The BMI classification used was the World Health Organization (WHO) classification for adults: lean individuals (BMI \<18.5 kg/m^2^), normal individuals (BMI 18.5--24.9 kg/m^2^), overweight individuals (BMI 25.0--29.9 kg/m2), and obese individuals (BMI ≥30 kg/m^2^).

The following fasting blood biochemical tests were performed for all study participants using a conventional automated analyzer (Hitachi 7600, Tokyo, Japan): fasting blood glucose (FBG), insulin; total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), very low-density lipoprotein (VLDL). Liver function tests included alanine transaminase (ALT), aspartate transaminase (AST), γ-glutamyl-transpeptidase (GGT), total bilirubin (TBil), direct bilirubin (DBil), and uric acid (UA) levels.

The homeostatic model assessment insulin resistance (HOMA-IR) index was used to assess basal glucose and insulin concentrations. HOMA-IR scores were obtained by multiplying the fasting serum insulin level (μIU/mL) by the FBG level (mmol/L), and dividing the product by 22.5.

Each study participant underwent a FibroScan^®^ 502 test (Echosens, Paris, France) with an M-probe to measure liver stiffness (kPa) and the controlled attenuation parameter (CAP) that correlated with liver fibrosis and steatosis, respectively. All 35 patients met the histological diagnostic criteria for NAFLD. All control subjects had a CAP value \<240 dB/m and a liver stiffness measurement (LSM) value \<7.0 kPa, to confirm that they were free from fatty liver disease.

Liver histology
---------------

Patients with NAFLD (n=35) had undergone percutaneous liver biopsy with real-time ultrasound guidance. The liver biopsy specimens were fixed and stored in neutral buffered formalin, processed and embedded in paraffin wax blocks. The tissue sections were then cut onto glass slides. Hematoxylin and eosin (H&E) staining and Masson's trichrome staining for collagen and reticulin were routinely performed on all biopsies, and the results were assessed under light microscopy by experienced histopathologists, who were unaware of the patient's clinical and imaging history. NAFLD, including simple liver steatosis and NASH, was diagnosed according to the semi-quantitative histological scoring algorithm of hepatic steatosis, hepatocyte ballooning, and lobular inflammation. A SAF score was created for each case including steatosis (S), activity (A, ballooning + lobular inflammation), and liver fibrosis (F). A score that fulfilled the criteria of S≥~1~A≥~2~F~any~ was used to support the diagnosis of NASH \[[@b17-medscimonit-24-6946]\].

DNA extraction and bisulfite conversion
---------------------------------------

DNA extraction from peripheral blood samples was performed using a nucleic acid extraction kit (Qiagen, Hilden, Germany). The quality of the DNA was determined using a NanoDrop 2000c spectrophotometer (Thermo Fisher Scientific Inc., DE, USA). Bisulfite conversion of the DNA (500 ng/sample) was then performed according to the manufacturer's protocol using the EZ DNA Methylation Kit (Zymo Research, CA, USA) and a modified thermo-cycling procedure (Illumina, San Diego, CA, USA).

DNA methylation status was analyzed with a microarray approach using the Illumina Human Methylation450 BeadChip platform (Illumina, San Diego, CA, USA) to interrogate DNA methylation in an epigenome-wide association study (EWAS). The methylation level of each cytosine was calculated as the fluorescence intensity ratio of the methylated alleles to the unmethylated alleles, based on the Infinium type I probes and the Infinium type II probes and was expressed as a β value. The β values ranged from between 0 (unmethylated) and 1 (completely methylated) according to the combination of the Cy3 and Cy5 fluorescence intensities \[[@b18-medscimonit-24-6946]\]. Illumina Genome Studio^®^ Methylation module version 1.0 (Illumina, San Diego, CA, USA) was used to calculate the β value for each CpG site. Color balance adjustment was performed to normalize the samples between the two color channels using Genome Studio Illumina software (V2010.3). GenomeStudio was used to normalize the data using different internal controls that were present on the Illumina HumanMethylation450 BeadChip platform (Illumina, San Diego, CA, USA).

All probes were subsequently filtered according to the following requirements: detection of P-values \>0.05 in one or more samples; the presence of single nucleotide polymorphisms (SNPs) at the 10 bp 3′ end of the interrogating probe; and alignment with multiple locations on the X and Y chromosomes. The final number of valid CpG sites used for this study was 418,913. The global methylation level was compared between patients with NASH, patients with simple hepatic steatosis, and normal controls. The genomic distribution of the differentially methylated CpG sites was examined using the distribution of the CpG sites among all analyzed sites on the Illumina HumanMethylation450 BeadChip platform.

Pyrosequencing
--------------

The methylation of specific cytosines with CpG dinucleotides was quantified by pyrosequencing using PyroMark Q 96 MD (Qiagen, Hilden, Germany). The acyl-CoA synthetase long-chain family member 4 (*ACSL4*) gene was used for validation. The sequencing primers were as follows: forward (GTGATGGATTTTG-GGGTTTT), reverse (AAAACTCCCTAACCCTCAATTAC). Sequencing primers (GTATTTAGAGGGTTAG AAGTTAT) were obtained using Pyromark Assay Design software (version 2.0) (Qiagen, Hilden, Germany). Bisulfite-treated DNA was amplified via polymerase chain reaction (PCR) using the PyroMark PCR Kit (Qiagen, Hilden, Germany) and PyroMark CpG software (Qiagen, Hilden, Germany) to present the sequencing results.

Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis
---------------------------------------------------------------

The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway database was used to analyze the effect of differentially methylated CpG sites and to identify signaling pathways that were significantly related to CpG sites (*<http://www.genome.jp/kegg/pathway.html>*). The method of detection of the false discovery rate (FDR) was used to exclude false-positive results \[[@b19-medscimonit-24-6946],[@b20-medscimonit-24-6946]\].

Statistical analysis
--------------------

Normally distributed data were expressed as the mean ± standard deviation (SD) and as numbers and percentages. The non-normally distributed data were presented as the median and interquartile range (IQR). After methylation data pre-processing \[[@b21-medscimonit-24-6946]\], the Illumina Methylation Analyzer (IMA) R software package was used to perform t-tests following methylation data pre-processing. The P-values were adjusted using the Benjamini-Hochberg false discovery rate (FDR) procedure for multiple comparisons, in which an FDR \<5% was considered to be statistically significant. A multivariate linear regression model was used to analyze the associations between the DNA methylation levels of the identified genes and liver enzyme levels and lipid profiles as continuous variables, adjusted by gender, age and BMI. The potential associations between the histological features of NAFLD and DNA methylation levels were evaluated using Pearson's correlation coefficient (r). The diagnostic efficiencies of the candidate differentially methylated CpG sites were calculated through receiver-operating characteristic (ROC) curve analysis. An area under the curve (AUC) value \>0.8 was interpreted as indicating very good efficiency, and an AUC value between 0.6--0.8 was interpreted as indicating good efficiency. All statistical analysis was performed using SPSS software, version 17.0 (SPSS, IBM Inc., Chicago, IL). Statistical significance was based on P-values of \<0.05. Statistically significant correlations were shown using plots generated with GraphPad Prism^®^ software, version 6.0 C (GraphPad, La Jolla, CA, USA).

Results
=======

Demographic, clinical, and metabolic characteristics of the study participants
------------------------------------------------------------------------------

The demographic, clinical, and metabolic characteristics of the participants in this study are presented in [Table 1](#t1-medscimonit-24-6946){ref-type="table"}. Liver biopsies from 35 patients with NAFLD showed simple hepatic steatosis (n=18) and NASH (n=17), according to the SAF score. Among the total study participants (n=65), 30.8% were women (n=20). In addition to exhibiting changes in their serum laboratory profiles, patients with NAFLD presented increased serum levels of ALT, GGT, and UA, but showed no significant differences in FBG levels. In addition to presenting high serum levels of cytokeratin (CK)18-M30 and CK18-M65, which are direct measures of liver cell damage, apoptosis, and inflammation, high LSM values were found, but only in patients with NASH.

The global pattern of methylated DNA CpG sites in NAFLD
-------------------------------------------------------

Comparisons of global methylation levels in the peripheral blood leukocytes of patients with NAFLD phenotypes compared with the normal controls are shown in [Figures 1](#f1-medscimonit-24-6946){ref-type="fig"} and [2](#f2-medscimonit-24-6946){ref-type="fig"}. Among a total of 418,913 probes, the average DNA methylation levels were similar in the NASH, simple hepatic steatosis, and normal control groups in terms of their correlation with either the CpG site content or the gene nearest to their functional genome. Hypomethylation was observed in the region of CpG islands, its north shore and south shore area ([Figure 1](#f1-medscimonit-24-6946){ref-type="fig"}). Promoter areas were defined as transcription start site (TSS)1500, TSS200, the 5′ UTR and the first exon. The DNA methylation levels were lower in promoter areas in all three groups studied (simple hepatic steatosis, NASH, and control groups) ([Figure 2](#f2-medscimonit-24-6946){ref-type="fig"}). The circulating blood leukocytes of the 35 patients with simple hepatic steatosis (n=18) and NASH (n=17) exhibited 65 CpG sites, which represented 60 genes that were differentially methylated, compared with normal controls. In the simple hepatic steatosis group, 42 methylated CpG sites were found to be associated with increased levels of alanine transaminase (ALT), and 32 methylated CpG sites were associated with increased serum lipid profiles, including TC, HDL-C, LDL-C, and TG levels. In the NASH group, compared with the simple hepatic steatosis group, methylated CpG sites showed more significant correlations with the presence of lobular inflammation than with hepatic steatosis and fibrosis.

The 65 NAFLD-associated CpG sites, representing 60 genes, were found to be significantly methylated in individuals with NAFLD and normal controls based on a P-value of \<0.05 and a false discovery rate (FDR) of q\<0.05 ([Supplementary Table 1](#s1-medscimonit-24-6946){ref-type="supplementary-material"}). The methylation levels (β values) in more than half of the CpG sites (41 sites, 65.1%) were within the range of 0--0.2, suggesting that hypomethylation mostly characterized the NAFLD-associated CpG sites. [Figure 3](#f3-medscimonit-24-6946){ref-type="fig"} shows the top 19 CpG sites associated with NAFLD presenting the most significant increases or decreases in methylation. Cg13291296 (coding *GPR125*) showed the most significant methylation level, with a 36% point change. Additionally, in an analysis of the difference in DNA methylation levels between patients with simple hepatic steatosis and normal controls, 119 CpG sites were annotated to 106 genes ([Supplementary Table 2](#s2-medscimonit-24-6946){ref-type="supplementary-material"}). The gender of the study participant was not found to exert a statistically significant influence on methylation levels in this study.

Enrichment of gene-mapped CpG sites related to NAFLD in Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways
---------------------------------------------------------------------------------------------------------------

Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways were used to determine the enrichment of genes mapped to NAFLD-associated CpG sites before analyzing the association of clinical parameters with the NAFLD phenotypes ([Supplementary Table 3](#s3-medscimonit-24-6946){ref-type="supplementary-material"}). For the NAFLD-associated methylated CpG sites, the two top-ranked pathways involved ribosome biogenesis in eukaryotes (EF=8.56, q=0.010) and MAPK signaling (EF=2.59, q=0.011). Enriched genes related to metabolic pathways, cytokine-cytokine receptor interactions, and insulin signaling pathways were also found.

Because this study identified only 65 NAFLD-associated sites, all of these CpG sites were considered in the second KEGG pathway analysis for the association between DNA methylation and simple hepatic steatosis ([Supplementary Table 4](#s4-medscimonit-24-6946){ref-type="supplementary-material"}). This analysis identified genes that were mainly involved in vitamin digestion and absorption through enrichment factor (EF) analysis (EF=15.84, q=0.033) and in a particular pathway in cancer (EF=2.33, q=0.034). After a search of the relevant literature, genes that were involved in the endoplasmic reticulum, insulin signaling, and adipose tissue homeostasis were identified. Although these associations showed a lower EF, they are recognized as being associated with the pathogenesis of NAFLD. These simple hepatic steatosis-associated methylated CpG sites, together with the NAFLD-associated methylated CpG sites mentioned above, were then used to explore the relationship between DNA methylation and clinical parameters.

Association between DNA methylation and liver enzyme and lipid profiles
-----------------------------------------------------------------------

The evaluation of the relationship between DNA methylation and clinical parameters focused on the NAFLD-associated CpG sites and the other 15 selected simple hepatic steatosis-associated CpG sites (in alphabetical order by gene name: *ABCC1*, *ATP5G1*, *AXIN2*, *CPT1A*, *CRLS1*, *DDX20*, *LDHB*, *MAPK1*, *NFE2L2*, *PMM1*, *PTEN*, *RB1*, *SEH1L*, *SGMS1*, and *SLC5A6*) from the KEGG pathway analysis. Simple linear regression analysis showed that most of the CpG sites were closely related to lipid profiles and ALT levels. Regarding demographic and clinical parameters, these CpG sites were strongly linked to BMI and waist circumference. Multivariate linear regression analysis adjusted for age, gender, and BMI also verified the results (significant results are listed in [Supplementary Table 5](#s5-medscimonit-24-6946){ref-type="supplementary-material"}).

A total of 42 methylated CpG sites were found to correlate with ALT levels, and these correlations remained significant after adjustment for age, gender, and BMI. Additionally, the correlations between levels of GGT with cg03992938 (*CCDC13*), cg04787602 (*C1orf183*), and cg014451560 (*ARRDC1*) were statistically significant. There were 32 CpG sites associated with TG, TC, or LDL-C levels, indicating dyslipidemia. With regard to glucose metabolism in NAFLD, the CpG sites were searched, and the results showed that cg07953400 (*PIGQ*), cg06706068 (*RPUSD1*), and cg16416718 (*CAMTA1*) exhibited strong correlations with fasting blood glucose levels, while cg25456633, cg03992938 (*CCDC13*), and cg02013957 (*CAGE1*) were closely associated with the homeostatic model assessment insulin resistance (HOMA-IR) index.

Methylation of CpG sites associated with NAFLD and liver histology
------------------------------------------------------------------

As shown in [Table 2](#t2-medscimonit-24-6946){ref-type="table"}, a total of 23 CpG sites were partially correlated with the hitological characteristics of NAFLD. Among the CpG sites associated with increased serum ALT levels, three sites were inversely correlated with hepatic steatosis: cg19634213 (*PTEN*) (r=−0.358, P=0.035), cg01067963 (*MAPK1*) (r=−0.343, P=0.044), and cg05102190 (*ZYX*) (r=−0.357, P=0.035). Additionally, seven CpG sites were negatively correlated with lobular inflammation: cg19634213 (*PTEN*) (r=−0.37, P=0.029), cg16398128 (*ZNF622*) (r=−0.497, P=0.002), cg22185268 (*COMMD4*) (r=−0.341, P=0.045), cg22721468 (*SH3BP5L*) (r=−0.337, P=0.048), cg15226170 (*PMM1*) (r=−0.369, P=0.029), cg04787602 (*C1orf91*) (r=−0.522, P=0.032), and cg05102190 (*ZYX*) (r=−0.362, P=0.033). None of the ALT-associated CpG sites were found to be correlated with liver fibrosis.

Among the 32 CpG sites associated with lipid profiles, 11 were correlated with the histological characteristics of NAFLD: Cg00150500 (*HCFC1R1)* showed the strongest association with steatosis and lobular inflammation. Cg12473838 (*SSBP1*) showed a strong correlation with the following NAFLD histological features: steatosis (r=−0.704, P\<0.001), hepatocytes ballooning (r=−0.542, P\<0.001), lobular inflammation (r=−0.531, P\<0.001) and fibrosis (r=−0.219, P\<0.001). Additionally, cg13463639 (*SIGIRR*) and cg15653194 (*LFNG*) both showed a strong-to-moderate correlation with lobular inflammation (r=0.64, P\<0.001 and r=0.485, P=0.049, respectively). No methylated CpG sites associated with FBG levels or HOMA-IR scores were correlated with the histological features of NAFLD. Pearson's correlation coefficient (r) (Y-axis) between the liver histology parameters (X-axis) and the methylated DNA sites that were inversely or directly associated with NAFLD are plotted in [Figure 4](#f4-medscimonit-24-6946){ref-type="fig"}.

Differentially methylated CpG (DMCpG) sites as potential biomarkers in NAFLD
----------------------------------------------------------------------------

The DNA methylation levels of the CpG sites that were correlated with the histological features of NAFLD were re-tested, which showed that the methylation levels of the *ACSL4*, *CRLS1*, *CTP1A*, *SIGIRR*, *SSBP1*, and *ZNF622* genes were significantly different in patients with NASH compared with patients with simple hepatic steatosis. The areas under the receiver-operating characteristic (ROC) curves (AUROCs) for these six sites were 0.689 (95% CI, 0.556--0.821) for *ACSL4*, 0.742 (95% CI, 0.578--0.906) for *CRLS1*, 0.745 (95% CI, 0.581--0.910) for *CTP1A*, 0.882 (95% CI, 0.758--0.999) for *SIGIRR*, 0.817 (95% CI, 0.676--0.958) for *SSBP1*, and 0.735 (95% CI, 0.567--0.903) for *ZNF622* ([Figure 5](#f5-medscimonit-24-6946){ref-type="fig"}). These six sites showed significant effectiveness in discriminating between patients with NASH and patients with simple hepatic steatosis. The estimated cut-off values, sensitivities, specificities, positive predictive values (PPVs), and negative predictive values (NPVs) are listed in [Table 3](#t3-medscimonit-24-6946){ref-type="table"}. The effectiveness of these six sites was compared with that of serum CK18 M65 levels as a marker of inflammation and hepatocyte injury, and no significant differences were found.

Validation of *ACSL4* methylation by pyrosequencing
---------------------------------------------------

*ACSL4* (cg15536552) was selected for validation through bisulfite pyrosequencing. The pyrosequencing results indicated that the methylation level of *ACSL4* (cg15536552) was consistent with that determined by the Illumina HumanMethylation450 BeadChip platform (r=0.756, P\<0.0001). According to the SAF score, *ACSL4* was significantly hypomethylated in patients with NASH compared with patients with simple hepatic steatosis (P=0.004).

Discussion
==========

Epigenetic processes are now recognized to play a role in the progression of nonalcoholic fatty liver disease (NAFLD). The characterization of how these epigenetic processes result in changes associated with liver injury provides new insights related to disease diagnostics and management. DNA methylation refers to the addition of a methyl group at a CpG site, which can influence the function of DNA by activating or suppressing gene expression \[[@b22-medscimonit-24-6946]\]. CpG methylation is regarded as a 'molecular clock' during the progression of liver phenotypes from normal liver histology to simple hepatic steatosis to inflammation and fibrosis \[[@b23-medscimonit-24-6946]\].

In the present study, the application of differentially methylated CpG sites to assess NAFLD phenotypes using microarrays allowed the analysis of a large fraction of the DNA methylome and the identification of genes correlated with changes in DNA methylation in peripheral blood leukocytes. This differential methylation may directly influence normal epigenetic regulation and cause pathological changes. The main purpose of the present study was to identify differentially methylated CpG sites in peripheral blood leukocytes to determine epigenetic biomarkers that might exhibit a strong correlation with the clinical parameters and histological features of NAFLD.

First, we analyzed more than 410,000 CpG sites to demonstrate that nonalcoholic steatohepatitis (NASH) was associated with differential DNA methylation in comparison with normal livers and simple hepatic steatosis. The adoption of a statistical significance of q\<0.05 enabled the identification of methylated sites that were significantly associated with NAFLD and simple hepatic steatosis. The identified NAFLD-associated CpG sites were mostly hypomethylated, a phenomenon supported by previous work by Murphy et al., who showed that the livers of individuals with advanced NAFLD exhibited more hypomethylation than those of individuals with mild NAFLD \[[@b13-medscimonit-24-6946]\].

In this study, the top NAFLD-associated CpG sites, including *KCNQ3*, *FUT11*, *DUSP16, CAMTA1*, and *GTSE1*, appeared to present a close connection with NAFLD and a higher risk of developing HCC. Genes contributing to insulin resistance (*EHMT2*, *INSR*, *TARS2*, and *BRSK2*) and lipid metabolism (*RXRB*) were enriched. Additionally, at simple hepatic steatosis-associated CpG sites, some adipogenic and lipid metabolism genes were also enriched in adipocytokine and insulin signaling pathways (*CPT1A*, *PTEN*, *LDHB*, *SGMS1*, *PMM1*, *ATP5G1*, *CRLS1*, and *PIGQ*). These observations provide evidence that, as a condition associated with metabolic disorders, NAFLD is influenced by integrated epigenetic modifications, even at an early stage. This finding might form the basis for future identification of DNA methylation biomarkers and their use to estimate future disease risk \[[@b24-medscimonit-24-6946]\].

Increased serum levels of liver enzymes such as alanine aminotransferase (ALT), aspartate transaminase (AST), and γ-glutamyl-transpeptidase (GGT) are markers of liver injury \[[@b25-medscimonit-24-6946]\]. GGT affects the pro-oxidant roles played by molecular species originating during the catabolism of glutathione and promotes lipid peroxidation. Previous studies have shown a genetic effect on liver enzyme levels \[[@b26-medscimonit-24-6946]\]. In this study, the majority of the NAFLD-methylated CpG sites were associated with increased ALT levels, a connection that retained its significance even after adjustments for age, gender and body mass index (BMI). The analysis focused on the correlation of these CpG sites with the histological features of NAFLD. The differential methylation of CpG sites within *ZNF622*, *PTEN*, *COMMD4*, *SH3BP4L*, *PMM1*, *C1orf91*, and *ZYX* was associated with lobular inflammation. Some of these genes encode key enzymes that catalyze the initial steps of lipid, acetyl-CoA, and glucose metabolism and are members of insulin-like signaling pathways. Methylation differences in *ZYX* and *PTEN* were also correlated with steatosis, although no CpG sites associated with AST were identified.

The identification of methylation sites associated with liver enzymes and hepatic steatosis has recently been reviewed by Nano et al., who conducted an epigenome-wide association study and identified eight probes associated with serum GGT levels and one probe associated with serum ALT levels \[[@b16-medscimonit-24-6946]\]. As in the present study, they identified no probe associated with serum AST levels.

Future large-scale studies may produce different results from the present study. Individuals with simple hepatic steatosis seldom progress to clinically significant liver disease and are considered to exhibit mild NAFLD. However, in patients with NASH, hepatic steatosis may trigger a fibrogenic repair process that can lead to cirrhosis or hepatocellular carcinoma (HCC). Murphy et al. found relevant differences in methylation that distinguished between patients with advanced fibrosis from those with mild fibrosis \[[@b13-medscimonit-24-6946]\]. Although the present study employed the same technique for measuring DNA methylation, the approach taken for analyzing the differences between liver phenotypes was dissimilar. Also, our results supported the existence cross-talk between epigenetic features and liver enzymes at the identified CpG sites. Collectively, these observations may reflect the influential role of hepatic inflammation in simple hepatic steatosis at the epigenetic level, which contributes to progression toward NASH \[[@b27-medscimonit-24-6946]\].

The second main aim of this study focused on the CpG sites correlated with lipid profiles. Dysfunctional lipid metabolism causes hepatic fat accumulation. Increased serum free fatty acids (FFA) cause increased triglyceride (TG) and very low-density lipoprotein (VLDL) levels in hepatocytes and trigger lipid peroxidation. These effects are closely related to the progression of NAFLD \[[@b28-medscimonit-24-6946]\]. Also, circulating cytokine and adipokine levels as well as the associated mitochondrial dysfunction, lipotoxicity, endoplasmic reticulum damage and oxidative stress are involved in hepatic steatosis \[[@b29-medscimonit-24-6946]\]. The most common pattern of dyslipidemia in NAFLD is characterized by hypertriglyceridemia, high levels of low-density lipoprotein cholesterol (LDL-C), and low levels of high-density lipoprotein cholesterol (HDL-C). In patients with NASH, there is a significant increase in the levels of oxidized LDL-C. In this study, a total of 31 CpG sites associated with LDL-C were selected after a multivariate analysis adjusted for gender, age, and BMI. Pearson's correlation coefficient (r) was used to verify the correlations between the CpG sites and NAFLD histological features. Ten of the identified CpG sites (*CTP1A*, *LFNG*, *ZNF622*, *HCFC1R1*, *CH3BP5L*, *COMMD4*, *SIGIRR*, *LDHB*, *SSBP1*, and *C1ofr91*) were moderately correlated with lobular inflammation.

Previously published studies have shown that high serum levels of oxidized LDL can be considered a risk factor for NASH, as oxidized LDL-C interacts with immune cells and contributes to the inflammatory process, upregulates adhesion molecules, and induces inflammation by increasing reactive oxygen species (ROS) generation and apoptotic cell death, which are involved in the progression of NASH \[[@b30-medscimonit-24-6946]\]. In this study, DNA methylation was measured in peripheral blood leukocytes, and the results were consistent with the serum lipid profile data. According to Pearson's correlation coefficient (r) analysis, a close association was found between lobular inflammation and NAFLD-associated methylated CpG sites relevant to altered LDL-C levels, which might indicate that alterations in methylation levels also exert a direct or indirect influence on liver lobular inflammation that results in the onset of NASH.

The final part of this study highlighted six methylated CpG sites that differentiated NASH from simple hepatic steatosis (*ACLS4*, *CPT1A*, *CRLS1*, *SSBP1*, *SIGIRR*, and *ZNF622*). Cytokeratin (CK)18-M65 was selected as a reference standard, as it is one of the most commonly employed serum biomarkers for diagnosing NASH. A previously published meta-analysis showed that the area under the receiver-operating characteristic (AUROC) curve for CK18-M65 for the diagnosis of NASH was 0.71--0.93 (sensitivity 66%, specificity 82%) \[[@b31-medscimonit-24-6946]\]. The present study showed that *SSBP1* and *SIGIRR* presented good efficiency for discriminating between NASH and simple hepatic steatosis, with AUCs of 0.817 and 0.882, respectively.

Expression of the *SSBP1* gene has been reported to be associated with the development of obesity and has been found to increase lipid accumulation in the liver. The cholesterol content of cells has been reported to be significantly increased following *SSBP1* knockdown, indicating that *SSBP1* could inhibit cellular cholesterol synthesis and accumulation \[[@b32-medscimonit-24-6946]\]. *SIGIRR* (also known as *TIR8*) is a negative regulator of Toll-like receptor 4 (TLR4), which is upregulated in NAFLD and mediates NASH before the onset of liver fibrosis*.* The expression of the *SIGIRR* gene has also been shown to represent an important checkpoint in anti-cancer activity in natural killer (NK) cells \[[@b33-medscimonit-24-6946]\].

Arachidonic acid preferred long-chain acyl-CoA synthetase (*ACSL4*) is a key enzyme involved in fatty acid metabolism in a variety of tissues and in hepatic steatosis, even after adjustment for BMI. Upregulation of the *ACSL4* gene accelerates lipogenesis, whereas downregulation of *ACSL4* prevents the accumulation of cellular cholesterol \[[@b34-medscimonit-24-6946]\]. Previous study also reported leukocytic hypomethylated *ACSL4* an index for borderline/definitive NASH, with odds ratio (OR) at 11.44 and 95% confidence interval (CI) from 1.04 to 125.37 (P=0.046) \[[@b35-medscimonit-24-6946]\]. In that study, the NAFLD Activity Score (NAS) scoring system has been used for the stratification of clinical phenotypes of NAFLD. However, inflammation facilitates fibrosis, while the prognosis of steatosis is still controversial. NAS scoring system is no longer recommended for the diagnosis of NASH because of its low prognostic value \[[@b36-medscimonit-24-6946]\]. In our study, we used SAF score instead, a system that complements the histopathological evaluation by dissociating hepatic steatosis from inflammation. This system helps to avoid some special cases from being excluded, as in some advanced cases, the liver may display ballooning and lobular inflammation with rare fat vacuoles, and provides a more accurate evaluation of NAFLD with better reproducibility \[[@b37-medscimonit-24-6946]\]. In our study, *ACSL4* retains an effective diagnosis value with AUROC at 0.742 (0.578--0.906) for the stratification of NASH in NAFLD.

*CPT1A* is a protein-encoding gene that plays an important role in the mitochondrial transport of carnitine, which results in a decrease in fatty acid beta-oxidation, and DNA methylation of the CpG sites of the *CPT1A* gene has been reported to be associated with increased lipid levels and metabolic syndrome \[[@b38-medscimonit-24-6946]\]. The *CRLS1* gene encodes cardiolipin, which is a phospholipid located in the inner mitochondrial membrane. The mitochondrial membrane is particularly susceptible to attack by ROS, resulting in damage to mitochondrial proteins, lipids and mitochondrial DNA, which can cause hepatocyte injury in NAFLD. Additionally, loss of cardiolipin leads to the generation of excessive levels of reactive oxygen species (ROS) that promote lipid peroxides and may cause oxidation of cardiolipin, catalyzed by cytochrome-c, resulting in apoptosis \[[@b39-medscimonit-24-6946],[@b40-medscimonit-24-6946]\]. The *ZNF622* gene (also known as *ZPR9*) encodes a multiprotein that is involved in the apoptosis signal-regulating kinase 1 (ASK1) and transforming growth factor (TGF)-β signaling pathway, and downregulation of ASK1 and TGF-β signaling activity can result in reduced intracellular lipid deposition.

Finally, this study identified a group of genes with a transcriptional status that was significantly correlated with DNA methylation levels, and this relationship differed between the NAFLD phenotypes. The findings of this study further showed that the methylated CpG sites detected in peripheral blood leukocytes were strongly associated with liver enzyme levels and lipid profiles, which are relevant to the outcomes of liver injury, impaired lipid metabolism, and the histological features of NAFLD. The findings of this study may have implications for the diagnosis of NAFLD, particularly for the diagnosis and evaluation of the severity of NASH, with differentially methylated CpG sites functioning as diagnostic or prognostic biomarkers. Epigenetic modifications might serve as malleable targets for future interventions that aim to detect or reverse advanced NAFLD.

The main challenge of this study was to assess the cause of NAFLD, as there was no evidence to explain why methylation facilitates lobular inflammation or why lobular inflammation in the progression of NASH alters methylation levels. All of these research questions require additional study. A further limitation of the study was that DNA methylation was measured in peripheral blood leukocytes, rather than in liver tissue, which may not be relevant to findings in the liver. Additionally, this study did not include gene expression analysis, and RNA samples were not available. As a result, differential DNA methylation was not studied directly from the analysis of the samples exhibiting the histological features of the NAFLD phenotypes. The whole-blood samples used in this study provided leukocytes for analysis, which were employed for quantifying DNA methylation levels, and allowed correlations with liver enzymes levels and lipid profiles to be assessed. Therefore, some CpG sites important to NAFLD might not have been detected in this study.

Conclusions
===========

The findings of this clinical study showed that DNA methylation sites in peripheral blood leukocytes correlated with changes in serum liver enzyme levels and lipid profiles and with histologically confirmed forms of nonalcoholic fatty liver disease (NAFLD) that included simple steatosis and nonalcoholic steatohepatitis (NASH) when compared with healthy controls. The study identified six differentially methylated CpG sites in genes including *ACSL4*, *CPT1A*, *SSBP1*, *CRLS1*, *ZNF622*, and *SIGIRR* in NAFLD patients. In the simple hepatic steatosis group, 42 methylated CpG sites were found to be associated with the increased serum levels of alanine aminotransferase (ALT), and 32 methylated CpG sites were associated with the altered lipid profiles in the blood. In the NASH group, altered methylation of CpG sites showed a more close correlation with the presence of hepatic lobular inflammation, seen histologically on liver biopsy. These results suggest that changes in methylated CpG sites can be detected in peripheral blood leukocytes in patients with NAFLD, and these blood-based biomarkers may have potential value for clinical research and diagnosis of NASH.

Supplementary Tables
====================

###### 

Individual CpG sites associated with NAFLD (q\<0.05) in circulating leukocytes. (N=64).

  Probe ID     *p* NAFLD   *q* NAFLD   NAFLD mean β   CL mean β   Difference (% points)   Gene symbol        UCSC RefGene Acession                                                          Relation to gene region     Relation to CpG island
  ------------ ----------- ----------- -------------- ----------- ----------------------- ------------------ ------------------------------------------------------------------------------ --------------------------- ------------------------
  cg00150500   5.05E-08    0.003526    0.040611       0.026409    0.014201229             HCFC1R1; THOC6     NM_017885; NM_001002018; NM_001002017; NM_001142350; NM_024339                 Body; TSS1500               Island
  cg01693328   3.78E-06    0.037736    0.734933       0.689903    0.045030407                                                                                                                                           S_Shelf
  cg02013957   2.80E-07    0.008217    0.069828       0.108342    −0.03851329             CAGE1; RIOK1       NM_205864; NM_031480; NM_001170693; NM_001170692                               TSS1500; Body               S_Shore
  cg03511638   7.43E-06    0.04944     0.207524       0.192478    0.015045277             FBXL15             NM_024326; NM_024326                                                           1^st^ Exon; 5′UTR           Island
  cg03615240   2.36E-06    0.029878    0.234903       0.217214    0.01768861                                                                                                                                            Island
  cg03753066   2.57E-06    0.029878    0.042778       0.033719    0.009058818             PGPEP1             NM_017712                                                                      TSS200                      N_Shore
  cg03956053   4.68E-06    0.040684    0.094807       0.069568    0.025238064                                                                                                                                           Island
  cg03992938   7.18E-06    0.04944     0.201834       0.1878      0.014034138             CCDC13             NM_144719; NM_144719                                                           1^st^ Exon; 5′UTR           Island
  cg04160753   5.99E-06    0.046488    0.275213       0.255442    0.019770564             C10orf91           NM_173541                                                                      TSS1500                     
  cg04396550   3.68E-12    1.54E-06    0.037964       0.025583    0.012380549             KCNQ3              NM_004519                                                                      TSS1500                     Island
  cg04787602   2.61E-07    0.008217    0.161306       0.144232    0.017073828             C1orf183           NM_198926; NM_019099                                                           Body; TSS1500               Island
  cg04981696   5.54E-07    0.012898    0.559923       0.491968    0.067954905             ABCC1              NM_019862; NM_019898; NM_019899; NM_004996; NM_019900                          Body                        S_Shore
  cg05102190   7.38E-06    0.04944     0.292254       0.261536    0.030718122             ZYX                NM_003461; NM_001010972                                                        TSS200                      Island
  cg06706068   6.62E-06    0.04866     0.450319       0.399254    0.051064413             RPUSD1             NM_058192                                                                      3′UTR                       N_Shore
  cg07067744   6.97E-06    0.04944     0.920563       0.90232     0.018243335             BRSK2              NM_003957                                                                      Body                        
  cg07112456   6.04E-07    0.013311    0.931972       0.912429    0.019543021             LRWD1              NM_152892                                                                      Body                        S_Shelf
  cg07953400   1.74E-06    0.02696     0.054226       0.045265    0.008961501             PIGQ               NM_004204; NM_148920                                                           TSS1500; TSS1500            N_Shore
  cg07956264   1.06E-07    0.006374    0.060192       0.042644    0.017547367             GPATCH3            NM_022078                                                                      1^st^ Exon                  Island
  cg08013262   2.14E-06    0.028915    0.051125       0.040134    0.010991397             INSR               NM_000208; NM_001079817                                                        Body                        Island
  cg09367046   6.48E-06    0.048457    0.078046       0.057973    0.020073316             ANGEL1             NM_015305                                                                      TSS200                      Island
  cg09826692   3.66E-07    0.009581    0.695734       0.717446    −0.0217123                                                                                                                                            Island
  cg10077144   6.43E-06    0.048457    0.151084       0.136608    0.014476221                                                                                                                                           Island
  cg10178228   2.57E-06    0.029878    0.16383        0.11116     0.052670088             FRMD4B             NM_015123                                                                      TSS200                      S_Shore
  cg10576516   2.94E-07    0.008217    0.046487       0.034138    0.01234886              RECQL5; SAP30BP    NM_001003716; NM_013260; NM_001003715; NM_013260; NM_004259                    TSS200; 1^st^ Exon; 5′UT    Island
  cg12289509   9.38E-07    0.019426    0.12632        0.116298    0.010022888             TUBE1              NM_016262; NM_001033564                                                        Body; TSS200                Island
  cg12362980   3.73E-06    0.037736    0.890648       0.915371    −0.02472296                                                                                                                                           Island
  cg13291296   1.94E-06    0.028151    0.928293       0.567811    0.360481701             GPR125             NM_145290                                                                      Body                        
  cg13373361   9.74E-07    0.019426    0.972063       0.958036    0.014027139             MYH16              NR_002147                                                                      Body                        
  cg13397649   2.39E-06    0.029878    0.184331       0.171045    0.013286234             AFG3L2             NM_006796                                                                      1^st^ Exon                  Island
  cg13463639   1.14E-07    0.047685    0.795196       0.744952    0.050244062             SIGIRR             NM_001135053; NM_021805                                                        TSS1500                     S_Shore
  cg13920768   4.76E-06    0.040684    0.180692       0.16038     0.02031251              PRDM12             NM_021619                                                                      3′UTR                       Island
  cg14214745   1.61E-06    0.025892    0.030079       0.02396     0.006119444             CRELD1             NM_001077415; NM_001031717; NM_015513; NM_015513; NM_001077415; NM_001031717   1^st^ Exon; 5′UTR           Island
  cg14247318   2.91E-06    0.032137    0.06859        0.051255    0.017334521                                                                                                                                           S_Shore
  cg14451560   4.08E-06    0.038185    0.163369       0.130014    0.033355016             ARRDC1             NM_152285                                                                      TSS1500                     N_Shore
  cg15317837   4.86E-06    0.0407      0.082077       0.065888    0.016188353             GTPBP4             NM_012341                                                                      TSS1500                     Island
  cg15653194   1.99E-09    0.000271    0.077077       0.051633    0.025443482             LFNG               NM_001166355; NM_002304; NM_001040168; NM_001040167                            Body; TSS200                Island
  cg16105594   1.46E-06    0.025002    0.222788       0.206881    0.015907317             MEF2C              NM_001131005; NM_002397                                                        5′UTR; TSS1500              Island
  cg16261091   5.26E-06    0.042403    0.871221       0.768176    0.103045403             C17orf101; HEXDC   NM_175902; NM_173620; NM_024648                                                Body; TSS1500               N_Shore
  cg16357287   1.96E-07    0.007527    0.033464       0.022286    0.011177644             SEH1L              NM_001013437; NM_031216                                                        TSS1500                     N_Shore
  cg16398128   1.66E-07    0.007527    0.038963       0.025503    0.01345955              ZNF622             NM_033414; NM_033414                                                           5′UTR; 1^st^ Exon           Island
  cg16416718   4.04E-06    0.038185    0.168379       0.155538    0.012840944             CAMTA1             NM_015215                                                                      TSS1500                     Island
  cg16487280   1.11E-06    0.020289    0.163618       0.146336    0.017282797             MYBL2              NM_002466                                                                      TSS1500                     Island
  cg17162475   1.08E-06    0.020289    0.136101       0.120308    0.015793168             C6orf150           NM_138441                                                                      TSS200                      Island
  cg17176517   5.44E-06    0.042966    0.055192       0.043187    0.012004537             SNX4               NM_003794; NM_003794                                                           5′UTR; 1^st^ Exon           Island
  cg18570553   3.67E-06    0.037736    0.144011       0.128948    0.015063351             PRR15              NM_175887                                                                      TSS200                      N_Shore
  cg18848688   1.42E-08    0.001192    0.143981       0.325489    −0.18150742             LIFR               NM_001127671; NM_002310                                                        TSS1500; 5′UTR              Island
  cg19137662   1.98E-07    0.007527    0.045624       0.032493    0.013131109             NOP56              NM_006392; NR_031699; NR_027700; NR_003078                                     Body; TSS200                Island
  cg19189310   1.49E-06    0.025002    0.201487       0.18607     0.015416665             RPS10              NM_001014                                                                      5′UTR                       Island
  cg21786114   2.28E-07    0.007946    0.516219       0.460762    0.055456681             EHMT2              NM_006709; NM_025256                                                           TSS1500                     N_Shore
  cg22185268   3.99E-07    0.009831    0.026994       0.020076    0.006918145             COMMD4             NM_017828                                                                      TSS200                      Island
  cg22402398   2.50E-06    0.029878    0.939115       0.923689    0.015425828             FGR                NM_001042747; NM_005248; NM_001042729                                          TSS1500; 5′UTR              
  cg22598233   3.16E-06    0.033997    0.069128       0.056446    0.012681401             POLRMT             NM_005035                                                                      TSS200                      Island
  cg22721468   1.96E-06    0.028151    0.060214       0.04424     0.01597372              SH3BP5L            NM_030645                                                                      TSS1500                     Island
  cg22746421   1.52E-07    0.007527    0.87434        0.852661    0.021678989                                                                                                                                           
  cg23224405   2.59E-09    0.000271    0.064945       0.045018    0.019927219             DUSP16             NM_030640; NM_030640                                                           1^st^ Exon; 5′UTR           Island
  cg24199050   2.65E-06    0.029971    0.010376       0.006359    0.004017477             GTSE1              NM_016426; NR_024009                                                           TSS200                      Island
  cg24239690   7.36E-06    0.04944     0.196241       0.181611    0.014630372             FSCN1              NM_003088                                                                      Body                        S_Shore
  cg24689754   4.95E-06    0.0407      0.029538       0.020196    0.009341864             C19orf62           NM_001033549; NM_001033549; NM_014173; NM_014173                               5′UTR; 1^st^ Exon           
  cg25295726   1.84E-09    0.000271    0.181557       0.162827    0.018730389             FUT11              NM_173540                                                                      TSS200                      Island
  cg25456633   4.20E-06    0.038224    0.897003       0.878185    0.018817636                                                                                                                                           
  cg25818813   4.10E-06    0.038185    0.064429       0.050092    0.014336947             MERTK              NM_006343                                                                      Body                        Island
  cg26105057   2.02E-06    0.028151    0.160883       0.126787    0.034095982             PAN2               NM_014871; NM_001166279; NM_001127460; NM_014871; NM_001166279                 1^st^ Exon; 5′UTR; TSS200   Island
  cg26309655   4.66E-06    0.040684    0.16828        0.148223    0.02005632              TARS2              NM_025150                                                                      TSS200                      
  cg12473838   4.88E-06    0.028795    0.040501       0.031202    0.009299747             SSBP1              NM_003143; NR_015392                                                           TSS200; Body                Island
  cg26786980   6.79E-06    0.049042    0.220594       0.183155    0.037438788             RARB               NM_016152; NM_016152; NM_000965; NM_000965                                     5′UTR; 1^st^ Exon           

###### 

Individual CpG sites associated with simple hepatic steatosis (q\<0.05) in circulating leukocytes. (N=119).

  Probe ID     *p* Simple hepatic steatosis   *q* Simple hepatic steatosis   Simple hepatic steatosis mean β   CL mean β   Difference (% points)   Gene symbol          UCSC RefGene acession                                                                           Relation to gene region            Relation to CpG island
  ------------ ------------------------------ ------------------------------ --------------------------------- ----------- ----------------------- -------------------- ----------------------------------------------------------------------------------------------- ---------------------------------- ------------------------
  cg00150500   0.00000                        0.00005                        0.04354                           0.02641     0.01713                 HCFC1R1; THOC6       NM_017885; NM_001002018; NM_001002017; NM_001142350; NM_024339                                  Body; TSS1500                      Island
  cg00574958   0.00000                        0.02625                        0.13777                           0.19441     −0.05664                CPT1A; CPT1A         NM_001876; NM_001031847                                                                         5′UTR                              N_Shore
  cg00639286   0.00001                        0.03794                        0.11783                           0.09329     0.02454                 ATOX1                NM_004045                                                                                       Body                               Island
  cg00932007   0.00000                        0.02625                        0.07328                           0.04803     0.02525                 SERINC1; PKIB        NM_020755; NM_181794; NM_020755                                                                 1^st^ Exon; TSS200; 5′UTR          Island
  cg01067963   0.00001                        0.02968                        0.06460                           0.04919     0.01541                 MAPK1                NM_138957; NM_002745                                                                            TSS1500                            Island
  cg01216607   0.00001                        0.04888                        0.13731                           0.11167     0.02564                 ZNHIT1; PLOD3        NM_006349; NM_001084; NM_001084                                                                 TSS1500; 1^st^ Exon; 5′UTR         Island
  cg01525244   0.00000                        0.00830                        0.22203                           0.17144     0.05059                 CBX7                 NM_175709                                                                                       TSS200                             N_Shore
  cg01801101   0.00000                        0.02176                        0.31191                           0.27460     0.03730                 AMZ1                 NM_133463                                                                                       5′UTR                              N_Shore
  cg02432888   0.00001                        0.03410                        0.92622                           0.93604     −0.00982                SMARCA4              NM_001128845; NM_001128844; NM_001128848; NM_001128846; NM_003072; NM_001128849; NM_001128847   1^st^ Exon; Body                   N_Shelf
  cg02581963   0.00000                        0.00977                        0.09723                           0.06908     0.02816                 C10orf75             NR_026762                                                                                       TSS200                             Island
  cg03027241   0.00000                        0.01712                        0.35425                           0.42982     −0.07557                KCNG1                NM_002237                                                                                       3′UTR                              Island
  cg03069383   0.00001                        0.04806                        0.22846                           0.20088     0.02758                 RDH14                NM_020905                                                                                       1^st^ Exon                         Island
  cg03074984   0.00001                        0.04262                        0.22030                           0.19083     0.02947                 RPS6KA4              NM_003942; NM_001006944                                                                         TSS200                             Island
  cg03511638   0.00000                        0.02698                        0.21013                           0.19248     0.01765                 FBXL15               NM_024326; NM_024326                                                                            1^st^ Exon; 5′UTR                  Island
  cg03956053   0.00000                        0.00468                        0.10087                           0.06957     0.03130                                                                                                                                                                         Island
  cg03992938   0.00000                        0.02085                        0.20399                           0.18780     0.01619                 CCDC13               NM_144719; NM_144719                                                                            1^st^ Exon; 5′UTR                  Island
  cg04396550   0.00000                        0.00000                        0.03999                           0.02558     0.01440                 KCNQ3                NM_004519                                                                                       TSS1500                            Island
  cg04551440   0.00000                        0.02375                        0.06975                           0.05204     0.01771                 KATNAL1              NM_001014380; NM_032116                                                                         TSS200; 5′UTR                      Island
  cg04672769   0.00000                        0.01712                        0.10358                           0.08340     0.02017                 HARS                 NM_002109; NM_012208; NM_002109                                                                 5′UTR; TSS200; 1stExon             Island
  cg04699668   0.00000                        0.02654                        0.78765                           0.83452     −0.04687                                                                                                                                                                        N_Shore
  cg04781764   0.00000                        0.01704                        0.86144                           0.88530     −0.02387                WDR51B               NM_172240                                                                                       Body                               
  cg04787602   0.00000                        0.02085                        0.16300                           0.14423     0.01876                 C1orf183; C1orf183   NM_198926; NM_019099                                                                            Body; TSS1500                      Island
  cg04851352   0.00001                        0.04156                        0.32402                           0.30766     0.01637                                                                                                                                                                         Island
  cg04981696   0.00000                        0.01712                        0.55926                           0.49197     0.06730                 ABCC1                NM_019862; NM_019898; NM_019899; NM_004996; NM_019900                                           Body                               S_Shore
  cg05020775   0.00001                        0.03145                        0.11804                           0.09411     0.02393                 SNPH                 NM_014723                                                                                       TSS200                             Island
  cg05102190   0.00000                        0.01712                        0.30075                           0.26154     0.03922                 ZYX                  NM_003461; NM_001010972                                                                         TSS200                             Island
  cg05131957   0.00000                        0.02625                        0.08817                           0.06755     0.02062                 CRLS1; CRLS1         NM_019095; NM_019095; NM_001127458                                                              1^st^ Exon; 5′UTR; TSS1500         Island
  cg05209527   0.00001                        0.03018                        0.20213                           0.15172     0.05042                 SLC5A6               NR_028323; NM_080592; NM_021095; NM_016085; NM_001170795                                        TSS1500; Body; 5′UTR               S_Shore
  cg05377161   0.00001                        0.04888                        0.11639                           0.09404     0.02235                                                                                                                                                                         Island
  cg05629721   0.00000                        0.02654                        0.29331                           0.24457     0.04875                 PSMB8                NM_004159; NM_148919; NM_004159                                                                 5′UTR; TSS1500; 1^st^ Exon         S_Shore
  cg05977109   0.00000                        0.02085                        0.09199                           0.06838     0.02361                 SGMS1                NM_147156                                                                                       5′UTR                              Island
  cg06276429   0.00001                        0.04156                        0.21157                           0.17132     0.04025                 SLC39A7; RXRB        NM_006979; NM_021976; NM_001077516                                                              TSS1500; Body                      N_Shore
  cg07067659   0.00001                        0.03187                        0.03402                           0.02441     0.00961                 SLC7A5               NM_003486                                                                                       1^st^ Exon                         Island
  cg07112456   0.00001                        0.03536                        0.93287                           0.91243     0.02044                 LRWD1                NM_152892                                                                                       Body                               S_Shelf
  cg07953400   0.00001                        0.02968                        0.05508                           0.04526     0.00982                 PIGQ                 NM_004204; NM_148920                                                                            TSS1500                            N_Shore
  cg07956264   0.00000                        0.00228                        0.06267                           0.04264     0.02003                 GPATCH3              NM_022078                                                                                       1^st^ Exon                         Island
  cg08180934   0.00000                        0.02625                        0.05768                           0.04568     0.01200                 STRAP                NM_007178                                                                                       TSS200                             Island
  cg08276889   0.00000                        0.02375                        0.03778                           0.02814     0.00964                 LOC100133985         NR_024444                                                                                       Body                               Island
  cg08730728   0.00001                        0.04156                        0.10524                           0.07919     0.02606                                                                                                                                                                         Island
  cg09090048   0.00001                        0.03018                        0.21230                           0.18139     0.03091                 VPS26B; NCAPD3       NM_052875; NM_015261                                                                            TSS1500; Body                      Island
  cg09267087   0.00001                        0.04156                        0.67624                           0.64183     0.03441                                                                                                                                                                         
  cg09367046   0.00001                        0.04262                        0.07982                           0.05797     0.02184                 ANGEL1               NM_015305                                                                                       TSS200                             Island
  cg09457469   0.00000                        0.01698                        0.06248                           0.04671     0.01577                 YBX2                 NM_015982                                                                                       Body                               Island
  cg09826692   0.00000                        0.02375                        0.69472                           0.71745     −0.02273                                                                                                                                                                        Island
  cg10059171   0.00001                        0.03187                        0.07502                           0.05829     0.01674                 GPR89B               NM_016334; NM_016334                                                                            5′UTR; 1^st^ Exon                  Island
  cg10178228   0.00000                        0.00820                        0.17082                           0.11116     0.05966                 FRMD4B               NM_015123                                                                                       TSS200                             S_Shore
  cg10369688   0.00001                        0.03018                        0.15684                           0.13906     0.01778                 ZFP36                NM_003407                                                                                       Body                               Island
  cg10381071   0.00000                        0.01712                        0.15437                           0.20650     −0.05213                TLE3                 NM_020908; NM_001105192; NM_005078                                                              TSS1500                            Island
  cg10576516   0.00000                        0.00019                        0.05003                           0.03414     0.01589                 RECQL5; SAP30BP      NM_001003716; NM_013260; NM_001003715; NM_013260; NM_004259                                     TSS200; 1^st^ Exon; 5′UTR          Island
  cg10965669   0.00001                        0.02931                        0.80870                           0.82408     −0.01538                AXIN2                NM_004655                                                                                       Body                               Island
  cg11319362   0.00001                        0.04251                        0.08666                           0.06828     0.01838                 ARL6IP5              NM_006407; NM_006407                                                                            1^st^ Exon; 5′UTR                  Island
  cg11542063   0.00000                        0.02625                        0.05513                           0.03884     0.01629                 NFE2L2               NM_006164; NM_006164; NM_001145413; NM_001145412                                                5′UTR; 1^st^ Exon; TSS1500         Island
  cg11866422   0.00000                        0.02654                        0.06337                           0.05160     0.01177                                                                                                                                                                         Island
  cg12289509   0.00001                        0.04442                        0.12657                           0.11630     0.01027                 TUBE1; C6orf225      NM_016262; NM_001033564                                                                         Body; TSS200                       Island
  cg12362980   0.00000                        0.00307                        0.88730                           0.91537     −0.02807                                                                                                                                                                        Island
  cg12407666   0.00000                        0.02901                        0.12378                           0.10250     0.02128                 RIC8B                NM_018157                                                                                       TSS1500                            Island
  cg12810189   0.00001                        0.03920                        0.04387                           0.03696     0.00691                 BCAP29               NR_027830; NM_018844; NM_018844; NM_001008405                                                   Body; 1^st^ Exon; 5′UTR; TSS1500   Island
  cg12850793   0.00000                        0.02321                        0.15979                           0.14310     0.01669                 DENND5A              NM_015213                                                                                       TSS200                             Island
  cg13110034   0.00001                        0.03187                        0.07293                           0.06148     0.01145                 ANKRD34A; POLR3GL    NM_001039888; NM_032305                                                                         TSS1500; 5′UTR                     Island
  cg13199615   0.00001                        0.03018                        0.23755                           0.21115     0.02640                 KRTCAP2; TRIM46      NM_173852; NM_025058                                                                            TSS1500; Body                      N_Shore
  cg13398864   0.00000                        0.02433                        0.11061                           0.08598     0.02463                 SEC22A               NM_012430                                                                                       TSS200                             N_Shore
  cg13485756   0.00000                        0.02698                        0.09370                           0.08224     0.01146                 RB1                  NM_000321                                                                                       TSS200                             Island
  cg14022530   0.00000                        0.02698                        0.07371                           0.05385     0.01986                 SASS6; CCDC76        NM_194292; NM_019083                                                                            TSS200                             Island
  cg14214745   0.00000                        0.01698                        0.03114                           0.02396     0.00718                 CRELD1               NM_001077415; NM_001031717; NM_015513; NM_015513; NM_001077415; NM_001031717                    1^st^ Exon; 5′UTR                  Island
  cg14247318   0.00001                        0.03018                        0.06991                           0.05126     0.01865                                                                                                                                                                         S_Shore
  cg15043926   0.00000                        0.02698                        0.28089                           0.26430     0.01659                 STIM2                NM_001169117; NM_020860; NM_001169118                                                           Body                               Island
  cg15226170   0.00000                        0.02879                        0.37491                           0.31659     0.05832                 PMM1                 NM_002676                                                                                       TSS1500                            S_Shore
  cg15324256   0.00000                        0.02625                        0.05617                           0.04062     0.01555                 QTRTD1; KIAA1407     NM_024638; NM_020817                                                                            TSS1500; 1^st^ Exon                Island
  cg15324448   0.00000                        0.02625                        0.10020                           0.08001     0.02019                 ZNF643               NM_023070                                                                                       TSS200                             Island
  cg15536552   0.07584                        0.04796                        0.20583                           0.34740     −0.01416                ACSL4                NM_022977; NM_004458                                                                            5′UTR; 5′UTR                       N_Shore
  cg15572086   0.00000                        0.01698                        0.06120                           0.04806     0.01314                 C1orf203             NR_027645; NR_024126; NR_024124; NR_027646; NR_024125                                           TSS1500                            Island
  cg15653194   0.00000                        0.00394                        0.07660                           0.05163     0.02496                 LFNG                 NM_001166355; NM_002304; NM_001040168; NM_001040167                                             Body; TSS200                       Island
  cg16007711   0.00000                        0.01712                        0.11104                           0.08414     0.02689                 RHOBTB2              NM_001160036; NM_001160037; NM_015178                                                           Body; 5′UTR                        S_Shore
  cg16306148   0.00001                        0.03359                        0.01234                           0.00608     0.00626                 YBX1                 NM_004559                                                                                       TSS1500                            Island
  cg16357287   0.00000                        0.00228                        0.03588                           0.02229     0.01360                 SEH1L; SEH1L         NM_001013437; NM_031216                                                                         TSS1500                            N_Shore
  cg16398128   0.00000                        0.00000                        0.04360                           0.02550     0.01810                 ZNF622               NM_033414; NM_033414                                                                            5′UTR; 1^st^ Exon                  Island
  cg16416718   0.00000                        0.02879                        0.16998                           0.15554     0.01445                 CAMTA1               NM_015215                                                                                       TSS1500                            Island
  cg16743070   0.00000                        0.01721                        0.04222                           0.02640     0.01582                 MYST3                NM_001099413; NM_001099412; NM_006766                                                           5′UTR                              Island
  cg16803522   0.00000                        0.01441                        0.03705                           0.02603     0.01102                 RASGRP1              NM_001128602; NM_005739                                                                         TSS1500                            Island
  cg17074213   0.00001                        0.02901                        0.20986                           0.15861     0.05125                 TGFBR3               NM_003243; NM_003243                                                                            1^st^ Exon; 5′UTR                  Island
  cg17162475   0.00000                        0.02375                        0.13817                           0.12031     0.01786                 C6orf150             NM_138441                                                                                       TSS200                             Island
  cg17168242   0.00000                        0.01599                        0.09273                           0.08238     0.01035                 OTUD7B               NM_020205                                                                                       TSS200                             Island
  cg17176517   0.00001                        0.04039                        0.05653                           0.04319     0.01334                 SNX4                 NM_003794; NM_003794                                                                            5′UTR; 1^st^ Exon                  Island
  cg17427781   0.00001                        0.04227                        0.08943                           0.07059     0.01884                 DDX20; C1orf183      NM_007204; NM_198926                                                                            TSS200; Body                       Island
  cg18676790   0.00001                        0.03018                        0.27930                           0.34935     −0.07005                                                                                                                                                                        
  cg18848688   0.00001                        0.02968                        0.14296                           0.32549     −0.18253                LIFR                 NM_001127671; NM_002310                                                                         TSS1500; 5′UTR                     Island
  cg19050851   0.00000                        0.02690                        0.03973                           0.02876     0.01097                 ARSB                 NM_000046; NM_198709                                                                            Body; Body                         Island
  cg19137662   0.00000                        0.01441                        0.04705                           0.03249     0.01455                 NOP56                NM_006392; NR_031699; NR_027700; NR_003078                                                      Body; TSS200; TSS1500              Island
  cg19362196   0.00000                        0.02625                        0.70650                           0.76251     −0.05601                STMN1                NM_005563; NM_203399; NM_203401; NM_001145454                                                   TSS1500                            Island
  cg19520115   0.00000                        0.00160                        0.12095                           0.10488     0.01607                 CAPZB                NM_004930                                                                                       Body                               Island
  cg19634213   0.00000                        0.01712                        0.05716                           0.04074     0.01643                 PTEN; KILLIN         NM_000314; NM_001126049                                                                         TSS1500; 1^st^ Exon                Island
  cg19693031   0.00001                        0.03187                        0.80756                           0.85146     −0.04390                TXNIP                NM_006472                                                                                       3′UTR                              
  cg19878987   0.00000                        0.02280                        0.10362                           0.08020     0.02342                 LDHB                 NM_002300                                                                                       TSS1500                            S_Shore
  cg20656751   0.00000                        0.02625                        0.51357                           0.47261     0.04096                 NAT8L                NM_178557                                                                                       1stExon                            Island
  cg21012729   0.00001                        0.03763                        0.08208                           0.06527     0.01681                 NIN                  NM_182946; NM_020921; NM_182944                                                                 5′UTR                              Island
  cg21373806   0.00001                        0.04156                        0.83546                           0.86386     −0.02840                BAHCC1               NM_001080519                                                                                    Body                               N_Shore
  cg21786114   0.00001                        0.03187                        0.51357                           0.46076     0.05281                 EHMT2                NM_006709; NM_025256                                                                            TSS1500                            N_Shore
  cg22185268   0.00000                        0.00217                        0.02871                           0.02008     0.00864                 COMMD4               NM_017828                                                                                       TSS200                             Island
  cg22721468   0.00000                        0.00228                        0.06494                           0.04424     0.02070                 SH3BP5L              NM_030645                                                                                       TSS1500                            Island
  cg22746421   0.00000                        0.01712                        0.87645                           0.85266     0.02379                                                                                                                                                                         
  cg22902478   0.00001                        0.04156                        0.10027                           0.08525     0.01502                 LOC100130987         NR_024469                                                                                       TSS200                             Island
  cg23224405   0.00000                        0.00011                        0.06783                           0.04502     0.02281                 DUSP16               NM_030640; NM_030640                                                                            1^st^ Exon; 5′UTR                  Island
  cg23348158   0.00000                        0.01712                        0.09342                           0.06174     0.03168                 FUZ                  NM_025129                                                                                       TSS200                             S_Shore
  cg23512165   0.00000                        0.02085                        0.02886                           0.02041     0.00845                 MTMR4                NM_004687; NM_004687                                                                            1^st^ Exon; 5′UTR                  Island
  cg24108286   0.00001                        0.03145                        0.25285                           0.21178     0.04107                 TFDP1                NR_026580; NM_007111                                                                            TSS1500                            
  cg24689754   0.00000                        0.02433                        0.03045                           0.02020     0.01026                 C19orf62             NM_001033549; NM_001033549; NM_014173; NM_014173                                                5′UTR; 1^st^ Exon                  
  cg24728479   0.00001                        0.03187                        0.19258                           0.17546     0.01712                 ZNF252; C8orf77      NR_023392; NR_026974                                                                            TSS1500; Body                      Island
  cg25053907   0.00001                        0.02968                        0.06377                           0.05198     0.01179                 ZNF721; PIGG         NM_133474; NM_017733; NM_001127178; NM_133474                                                   5′UTR; TSS200; 1^st^ Exon          Island
  cg25295726   0.00000                        0.01101                        0.18162                           0.16283     0.01879                 FUT11                NM_173540                                                                                       TSS200                             Island
  cg25678532   0.00000                        0.02625                        0.05138                           0.03889     0.01249                 RBBP8                NM_203291; NM_203292; NM_002894                                                                 TSS1500; TSS200                    Island
  cg25818813   0.00000                        0.02014                        0.06671                           0.05009     0.01661                 MERTK                NM_006343                                                                                       Body                               Island
  cg25856120   0.00001                        0.04680                        0.11157                           0.08244     0.02914                 ATP5G1               NM_005175; NM_005175; NM_001002027                                                              1^st^ Exon; 5′UTR                  S_Shore
  cg25989057   0.00001                        0.02942                        0.03813                           0.02660     0.01154                 AIP                  NM_003977                                                                                       TSS200                             Island
  cg26309655   0.00001                        0.04156                        0.17136                           0.14822     0.02314                 TARS2                NM_025150                                                                                       TSS200                             
  cg26462136   0.00001                        0.03647                        0.08411                           0.06628     0.01783                 ATXN7L3              NM_001098833; NM_020218                                                                         TSS1500                            Island
  cg26791384   0.00001                        0.04156                        0.25191                           0.21622     0.03569                 SYCE1L               NM_001129979                                                                                    Body                               Island
  cg26824705   0.00001                        0.04888                        0.08142                           0.06402     0.01740                 MUL1                 NM_024544                                                                                       TSS200                             Island
  cg27164612   0.00000                        0.02654                        0.01342                           0.00813     0.00529                                                                                                                                                                         
  cg27612695   0.00000                        0.02625                        0.18852                           0.15615     0.03238                 SUZ12P               NR_024187                                                                                       Body                               S_Shore

###### 

Significantly enriched KEGG pathways of genes with altered DNA methylation level in NAFLD.

  Pathway ID   Description                         p Value   q Value   Genes                                      Enrich factor
  ------------ ----------------------------------- --------- --------- -------- --------------------------------- ---------------
  hsa03008     Ribosome biogenesis in eukaryotes   0.004     0.010     GTPBP4   GTP binding protein4              8.56
  NOP56        Ribonucleo protein                                                                                 
  hsa04010     MAPK signaling pathway              0.001     0.011     DUSP16   Dual specificity phosphatase 16   2.59
  MEF2C        Myocyte enhancer factor 2C                                                                         

###### 

Significantly enriched KEGG pathways of genes with altered DNA methylation level in simple hepatic steatosis.

  Pathway ID   Description                                p Value   q Value   Genes                                       Enrich factor
  ------------ ------------------------------------------ --------- --------- -------- ---------------------------------- ---------------
  hsa04977     Vitamin digestion and absorption           0.0007    0.033     SLC5A6   Solute carrier family 5 member 6   15.84
  ABCC1        ATP binding cassette sub familyC member1                                                                   
  hsa03013     RNAtransport                               0.0100    0.040     DDX20    DEAD-box helicase 20               2.50
  SEH1L        SEH1 like nucleoporin                                                                                      
  hsa05200     Pathways in cancer                         0.0070    0.034     PTEN     Phosphatase and tensin homolog     2.33
  AXIN2        Axin 2                                                                                                     
  MAPK1        Mitogen-activated protein kinase 1                                                                         
  RB1          RB transcriptional corepressor 1                                                                           

###### 

Significance of associations between biological parameters and selected methylated CpG sites.

  Illumina ID   Gene symbol   GLU     HOMAIN      TG      TC          HDL     LDL         GGT     ALT         AST                                                                                 
  ------------- ------------- ------- ----------- ------- ----------- ------- ----------- ------- ----------- ------- ------- ------- ----------- ------- ----------- ------- ----------- ------- -------
  cg00150500    HCFC1R1       0.492   0.736       0.290   0.433       0.020   0.545       0.008   0.027^\*^   0.505   0.516   0.000   0.005^\*^   0.107   0.132       0.006   0.057       0.792   0.668
  cg00574958    CTP1A         0.333   0.435       0.433   0.768       0.001   0.001^\*^   0.017   0.308       0.067   0.575   0.000   0.001^\*^   0.125   0.417       0.034   0.478       0.340   0.657
  cg01067963    MAPK1         0.321   0.685       0.520   0.963       0.039   0.795       0.216   0.632       0.070   0.316   0.018   0.259       0.365   0.201       0.006   0.035^\*^   0.603   0.454
  cg01693328                  0.899   0.875       0.408   0.665       0.247   0.816       0.126   0.170       0.173   0.441   0.087   0.165       0.162   0.174       0.002   0.009^\*^   0.111   0.185
  cg01801101    AMZ1          0.971   0.949       0.392   0.838       0.006   0.211       0.240   0.280       0.287   0.844   0.016   0.078       0.983   0.932       0.000   0.002^\*^   0.818   0.488
  cg02013957    CAGE1         0.860   0.788       0.010   0.010^\*^   0.049   0.371       0.213   0.951       0.051   0.656   0.150   0.413       0.133   0.122       0.001   0.024^\*^   0.498   0.082
  cg03511638    FBXL15        0.158   0.282       0.136   0.258       0.129   0.930       0.585   0.985       0.373   0.908   0.073   0.446       0.113   0.141       0.010   0.070       0.588   0.818
  cg03615240                  0.147   0.757       0.286   0.355       0.101   0.206       0.036   0.142       0.816   0.237   0.012   0.012^\*^   0.179   0.400       0.000   0.033^\*^   0.061   0.373
  cg03992938    CCDC13        0.107   0.296       0.067   0.032^\*^   0.844   0.139       0.035   0.449       0.404   0.240   0.001   0.006^\*^   0.016   0.021^\*^   0.012   0.011^\*^   0.187   0.882
  cg04160753    C10orf91      0.162   0.316       0.936   0.880       0.014   0.105       0.030   0.161       0.466   0.798   0.014   0.108       0.295   0.361       0.104   0.345       0.904   0.986
  cg04787602    C1orf183      0.153   0.304       0.328   0.396       0.044   0.271       0.058   0.914       0.046   0.259   0.001   0.039^\*^   0.033   0.035^\*^   0.001   0.010^\*^   0.181   0.207
  cg04981696    ABCC1         0.260   0.318       0.420   0.784       0.046   0.090       0.055   0.778       0.470   0.645   0.002   0.033^\*^   0.657   0.736       0.000   0.004^\*^   0.777   0.547
  cg05102190    ZYX           0.116   0.122       0.972   0.880       0.039   0.084       0.056   0.360       0.301   0.926   0.025   0.077       0.338   0.365       0.005   0.030^\*^   0.812   0.717
  cg05131957    CRLS1         0.091   0.199       0.489   0.876       0.032   0.274       0.068   0.312       0.585   0.892   0.006   0.047^\*^   0.995   0.780       0.018   0.069       0.483   0.196
  cg05209527    SLC5A6        0.143   0.519       0.254   0.407       0.141   0.919       0.040   0.109       0.563   0.908   0.005   0.506       0.923   0.353       0.000   0.006^\*^   0.478   0.317
  cg06706068    RPUSD1        0.034   0.020^\*^   0.477   0.970       0.533   0.052       0.032   0.268       0.090   0.748   0.023   0.049^\*^   0.233   0.243       0.003   0.043^\*^   0.851   0.586
  cg07067744    BRSK2         0.782   0.974       0.454   0.760       0.093   0.104       0.038   0.963       0.389   0.782   0.003   0.030^\*^   0.360   0.435       0.012   0.108       0.694   0.757
  cg07112456    LRWD1         0.167   0.261       0.370   0.531       0.230   0.199       0.071   0.660       0.470   0.664   0.033   0.178       0.082   0.097       0.031   0.208       0.475   0.480
  cg07953400    PIGQ          0.001   0.004^\*^   0.625   0.452       0.233   0.005^\*^   0.000   0.823       0.916   0.770   0.000   0.001^\*^   0.250   0.343       0.013   0.041^\*^   0.939   0.439
  cg07956264    GPATCH3       0.702   0.693       0.026   0.068       0.000   0.028^\*^   0.029   0.002^\*^   0.112   0.493   0.009   0.023^\*^   0.158   0.164       0.000   0.002^\*^   0.282   0.232
  cg08013262    INSR          0.582   0.678       0.482   0.695       0.031   0.046^\*^   0.023   0.242       0.850   0.569   0.013   0.061       0.847   0.952       0.001   0.005^\*^   0.859   0.992
  cg09367046    ANGEL1        0.275   0.356       0.557   0.793       0.109   0.351       0.190   0.811       0.203   0.624   0.022   0.118       0.175   0.205       0.000   0.002^\*^   0.198   0.188
  cg10077144                  0.722   0.544       0.467   0.283       0.006   0.203       0.029   0.084       0.645   0.736   0.007   0.138       0.950   0.711       0.002   0.004^\*^   0.776   0.621
  cg10178228    FRMD4B        0.566   0.705       0.482   0.603       0.447   0.937       0.668   0.196       0.005   0.055   0.078   0.357       0.240   0.270       0.000   0.005^\*^   0.838   0.776
  cg12289509    TUBE1         0.402   0.503       0.479   0.670       0.236   0.029^\*^   0.019   0.921       0.676   0.683   0.001   0.002^\*^   0.443   0.489       0.000   0.001^\*^   0.624   0.833
  cg12473838    SSBP1         0.004   0.167       0.500   0.711       0.419   0.928       0.000   0.192       0.000   0.664   0.001   0.030^\*^   0.122   0.140       0.755   0.199       0.453   0.765
  cg13291296    GPR125        0.652   0.802       0.697   0.967       0.034   0.101       0.064   0.256       0.063   0.211   0.010   0.028^\*^   0.242   0.253       0.012   0.057       0.752   0.820
  cg13397649    AFG3L2        0.090   0.227       0.678   0.749       0.003   0.809       0.305   0.079       0.133   0.385   0.038   0.295       0.898   0.948       0.017   0.082       0.301   0.156
  cg13463639    SIGIRR        0.082   0.551       0.618   0.985       0.376   0.709       0.002   0.348       0.028   0.363   0.009   0.020^\*^   0.375   0.275       0.980   0.730       0.298   0.431
  cg13920768    PRDM12        0.278   0.431       0.539   0.635       0.004   0.101       0.035   0.065       0.855   0.221   0.016   0.095       0.278   0.347       0.007   0.040^\*^   0.779   0.710
  cg14214745    CRELD1        0.764   0.627       0.141   0.246       0.001   0.419       0.207   0.024^\*^   0.022   0.196   0.048   0.218       0.883   0.713       0.041   0.267       0.314   0.359
  cg14247318                  0.405   0.309       0.206   0.361       0.052   0.009^\*^   0.017   0.146       0.456   0.718   0.004   0.004^\*^   0.224   0.215       0.011   0.031^\*^   0.648   0.821
  cg14451560    ARRDC1        0.132   0.129       0.282   0.480       0.075   0.191       0.117   0.452       0.044   0.182   0.022   0.076       0.040   0.047^\*^   0.014   0.078       0.796   0.810
  cg15226170    PMM1          0.894   0.780       0.422   0.625       0.024   0.354       0.136   0.352       0.511   0.911   0.012   0.095       0.302   0.203       0.001   0.009^\*^   0.535   0.537
  cg15317837    GTPBP4        0.920   0.942       0.194   0.550       0.005   0.682       0.507   0.282       0.012   0.244   0.166   0.460       0.650   0.708       0.016   0.254       0.127   0.472
  cg15536552    ACSL4         0.001   0.439       0.001   0.045^\*^   0.001   0.189       0.050   0.478       0.670   0.667   0.001   0.085       0.119   0.664       0.001   0.043^\*^   0.071   0.431
  cg15653194    LFNG          0.167   0.052       0.190   0.843       0.000   0.001^\*^   0.006   0.010^\*^   0.124   0.320   0.001   0.001^\*^   0.840   0.955       0.016   0.453       0.001   0.111
  cg16105594    MEF2C         0.228   0.481       0.701   0.832       0.042   0.234       0.067   0.437       0.020   0.064   0.002   0.022^\*^   0.411   0.500       0.026   0.124       0.086   0.213
  cg16261091    HEXDC         0.722   0.620       0.073   0.146       0.005   0.315       0.242   0.110       0.093   0.465   0.044   0.118       0.097   0.095       0.004   0.036^\*^   0.561   0.614
  cg16357287    SEH1L         0.574   0.745       0.092   0.138       0.081   0.183       0.110   0.446       0.126   0.361   0.008   0.025^\*^   0.773   0.709       0.000   0.003^\*^   0.644   0.386
  cg16398128    ZNF622        0.410   0.717       0.339   0.352       0.003   0.022^\*^   0.005   0.058       0.365   0.766   0.000   0.001^\*^   0.976   0.859       0.000   0.001^\*^   0.809   0.764
  cg16416718    CAMTA1        0.001   0.004^\*^   0.739   0.772       0.200   0.010^\*^   0.001   0.778       0.387   0.558   0.000   0.001^\*^   0.053   0.069       0.031   0.079       0.984   0.313
  cg16487280    MYBL2         0.082   0.070       0.708   0.744       0.183   0.112       0.064   0.488       0.989   0.067   0.006   0.027^\*^   0.671   0.497       0.081   0.624       0.004   0.060
  cg17162475    C6orf150      0.317   0.328       0.201   0.465       0.052   0.507       0.341   0.874       0.052   0.618   0.032   0.165       0.562   0.635       0.000   0.008^\*^   0.611   0.313
  cg17176517    SNX4          0.349   0.639       0.406   0.446       0.255   0.182       0.042   0.821       0.291   0.593   0.005   0.062       0.563   0.713       0.006   0.030^\*^   0.715   0.484
  cg18570553    PRR15         0.042   0.098       0.444   0.310       0.028   0.043^\*^   0.008   0.387       0.640   0.712   0.001   0.009^\*^   0.063   0.084       0.005   0.035^\*^   0.527   0.705
  cg18848688    LIFR          0.885   0.925       0.125   0.242       0.003   0.064       0.051   0.102       0.023   0.175   0.005   0.012^\*^   0.224   0.221       0.002   0.022^\*^   0.651   0.826
  cg19189310    RPS10         0.398   0.564       0.453   0.711       0.062   0.150       0.052   0.953       0.205   0.964   0.009   0.086       0.200   0.239       0.005   0.075       0.292   0.224
  cg19634213    PTEN          0.194   0.497       0.494   0.932       0.900   0.353       0.102   0.213       0.483   0.651   0.010   0.092       0.297   0.356       0.001   0.002^\*^   0.236   0.447
  cg19878987    LDHB          0.321   0.532       0.328   0.574       0.086   0.136       0.034   0.691       0.477   0.932   0.008   0.087       0.176   0.240       0.001   0.003^\*^   0.197   0.218
  cg21786114    EHMT2         0.344   0.374       0.953   0.367       0.023   0.073       0.060   0.841       0.363   0.484   0.004   0.029^\*^   0.600   0.654       0.001   0.018^\*^   0.809   0.483
  cg22185268    COMMD4        0.943   0.744       0.548   0.618       0.007   0.180       0.058   0.108       0.299   0.842   0.001   0.019^\*^   0.329   0.431       0.001   0.008^\*^   0.467   0.844
  cg22746421                  0.798   0.779       0.030   0.105       0.130   0.237       0.205   0.633       0.011   0.241   0.021   0.054       0.302   0.289       0.002   0.038^\*^   0.163   0.527
  cg23224405    DUSP16        0.873   0.594       0.099   0.062       0.024   0.256       0.053   0.351       0.099   0.194   0.002   0.054       0.147   0.199       0.000   0.001^\*^   0.197   0.435
  cg24199050    GTSE1         0.064   0.175       0.949   0.862       0.012   0.006^\*^   0.001   0.129       0.719   0.984   0.000   0.001^\*^   0.754   0.988       0.004   0.013^\*^   0.717   0.190
  cg24689754    C19orf62      0.357   0.466       0.273   0.341       0.147   0.607       0.366   0.576       0.102   0.183   0.007   0.045^\*^   0.731   0.593       0.001   0.005^\*^   0.368   0.104
  cg25295726    FUT11         0.685   0.906       0.175   0.314       0.056   0.231       0.094   0.748       0.030   0.184   0.007   0.050       0.112   0.130       0.003   0.040^\*^   0.699   0.746
  cg25456633                  0.613   0.938       0.003   0.003^\*^   0.080   0.581       0.235   0.649       0.296   0.688   0.085   0.377       0.626   0.742       0.001   0.012^\*^   0.893   0.758
  cg25818813    MERTK         0.131   0.253       0.968   0.926       0.087   0.037^\*^   0.015   0.264       0.848   0.545   0.000   0.002^\*^   0.478   0.550       0.000   0.001^\*^   0.179   0.513
  cg26105057    PAN2          0.843   0.972       0.305   0.831       0.029   0.122       0.161   0.401       0.107   0.656   0.058   0.082       0.155   0.137       0.000   0.002^\*^   0.522   0.167
  cg26309655    TARS2         0.103   0.299       0.820   0.667       0.065   0.172       0.032   0.301       0.671   0.670   0.006   0.077       0.391   0.514       0.004   0.008^\*^   0.757   0.542
  g22721468     SH3BP5L       0.097   0.225       0.616   0.649       0.232   0.106       0.028   0.816       0.618   0.787   0.000   0.009^\*^   0.465   0.569       0.001   0.008^\*^   0.643   0.882

1^\#^ -- Uni-variate p; 2^\#^ -- Multi-variate; p\* *p*\<0.05, adjusted by sex, age and BMI.

**Source of support:** This study was supported by the State Key Development Program for Basic Research of China (Ref: 2012CB517501), the National Natural Science Foundation of China (Refs: 81070322, 81270491, 81470840), and the 100 Talents Program of the Shanghai Board of Health (Ref: XBR2011007)

![Global DNA methylation in circulating leukocytes from normal controls, patients with simple hepatic steatosis, and patients with nonalcoholic steatohepatitis (NASH), showing CpG island regions. Global DNA methylation is calculated as the average DNA methylation (%) at all CpG sites in each annotated region, according to the Illumina HumanMethylation450 BeadChip platform, which was used to interrogate DNA methylation in an epigenome-wide association study (EWAS). Shore, flanking regions of CpG islands (0--2,000 bp). Shelf, regions flanking island shores (2,000--4,000 bp from the CpG island). N -- northern; S -- Southern. \* Significant difference (P\<0.05).](medscimonit-24-6946-g001){#f1-medscimonit-24-6946}

![Global DNA methylation in circulating leukocytes from normal controls, patients with simple hepatic steatosis, and patients with nonalcoholic steatohepatitis (NASH) is shown for each gene region. Transcription start site (TSS) represents the proximal promoter, defined as 200 bp or 1,500 bp upstream of the TSS. \* Significant difference (P\<0.05).](medscimonit-24-6946-g002){#f2-medscimonit-24-6946}

![CpG sites showing the most significant increase or decrease in DNA methylation (q\<0.05) in nonalcoholic fatty liver disease (NAFLD).](medscimonit-24-6946-g003){#f3-medscimonit-24-6946}

![Pearson's correlation coefficients (r) (Y-axis) between histological features (X-axis) and methylated DNA sites inversely or directly associated with nonalcoholic fatty liver disease (NAFLD).](medscimonit-24-6946-g004){#f4-medscimonit-24-6946}

![Receiver-operating characteristic (ROC) curves for the methylation levels of the nonalcoholic steatohepatitis (NASH)-related differentially methylated CpG sites.](medscimonit-24-6946-g005){#f5-medscimonit-24-6946}

###### 

Clinical characteristics of the participants.

                              NASH (n=17)               Simple hepatic steatosis (n=18)   NAFLD (n=35)              Control (n=30)            NAFLD *vs.* CL P-value
  --------------------------- ------------------------- --------------------------------- ------------------------- ------------------------- -----------------------------------------------------------------
  Sex (F) (N, %)              12 (70.6%)                15 (83.3%)                        8 (22.9%)                 12 (40.0%)                0.12[\*\*](#tfn2-medscimonit-24-6946){ref-type="table-fn"}
  BMI \>25 (N, %)             12 (70.6%)                14 (77.8%)                        26 (74.0%)                4 (13.0%)                 \<0.001[\*\*](#tfn2-medscimonit-24-6946){ref-type="table-fn"}
  Metabolic syndrome (N, %)   7 (41.2%)                 6 (33.3%)                         22 (63.0%)                0 (0.0%)                  \<0.001[\*\*](#tfn2-medscimonit-24-6946){ref-type="table-fn"}
  Central obesity (N, %)      13 (76.5%)                13 (72.2%)                        26 (74.0%)                9 (30.0%)                 0.01[\*\*](#tfn2-medscimonit-24-6946){ref-type="table-fn"}
  Age (y)                     37.76±12.77               37.72±12.48                       37.74±12.43               46.63±7.24                \<0.001
  HT (cm)                     167.76±6.69               169.44±5.83                       168.63±6.23               164.32±7.22               0.010
  WT (kg)                     76.88±11.15               79.97±13.38                       78.47±12.27               62.29±9.04                \<0.001
  BMI                         27.29±3.4                 27.79±3.84                        27.55±3.59                23.02±2.63                \<0.001
  FBG (mmol/L)                5.33±1.14                 6.22±3.68                         5.81±2.82                 5.29±0.39                 0.300
  TBIL (μmol/L)               12.36±3.31                19.86±21.9                        16.33±16.32               14.29±4.05                0.510
  DBIL (μmol/L)               7.23±10.12                9.64±19.58                        8.51±15.67                2.98±0.83                 0.050
  GGT (u/L)                   78.25 (44.03--131.00)     51.55 (32.50--80.70)              65.35 (36.48--88.78)      13.00 (11.00--17.25)      0.020[\*](#tfn1-medscimonit-24-6946){ref-type="table-fn"}
  ALT (u/L)                   70.48±40.78               75.61±64.31                       73.19±53.79               15.6±4.42                 \<0.001
  TC (mmol/L)                 4.99±0.65                 4.95±1.07                         4.97±0.91                 4.35±0.61                 \<0.001
  TG (mmol/L)                 2.37±2.13                 2.01±0.77                         2.17±1.5                  0.82±0.34                 \<0.001
  HDL-C (mmol/L)              1.23±0.34                 1.19±0.28                         1.21±0.3                  1.43±0.25                 \<0.001
  LDL-C (mmol/L)              2.8±0.66                  3.08±0.82                         2.97±0.76                 2.24±0.38                 \<0.001
  UA (μmol/L)                 413.16±122.29             362.02±110.02                     383.19±115.97             257.83±62.14              \<0.001
  CK18M 30 (ng/L)             537.44±317.21             362.03±162.21                                                                         \<0.001[\*\*\*](#tfn3-medscimonit-24-6946){ref-type="table-fn"}
  CK18M 65 (ng/L)             1159.32±613.07            829.94±421.69                                                                         \<0.001[\*\*\*](#tfn3-medscimonit-24-6946){ref-type="table-fn"}
  LSM (kpa)                   9.45 (6.08--14.40)        5.70 (4.35--9.95)                 7.60 (5.40--12.00)        4.15 (3.70--4.70)         \<0.001[\*](#tfn1-medscimonit-24-6946){ref-type="table-fn"}
  CAP (dB/m)                  328.50 (289.25--358.75)   310.00 (276.00--361.50)           310.00 (277.00--359.00)   195.00 (174.00--228.00)   \<0.001[\*](#tfn1-medscimonit-24-6946){ref-type="table-fn"}

Mann-Whitney test;

Pearson chi-square or Fisher's exact test;

NASH *vs.* Simple Hepatic Steatosis *P*-value.

FBG -- fasting blood glucose; TC -- total cholesterol; TG -- triglyceride; HDL-C -- high-density lipoprotein cholesterol; LDL-C -- low-density lipoprotein cholesterol; ALT -- alanine transaminase; AST -- aspartate transaminase; GGT -- γ-glutamyl-transpeptidase; TBIL -- total bilirubin; DBIL -- direct bilirubin; UA -- uric acid; CK18 -- cytokeratin-18; LSM -- liver stiffness measurement; CAP -- controlled attenuation parameter; N -- number. Normal distribution data are expressed as the means±standard deviations and as numbers and percentages. The non-normal distribution data are presented as the median and interquartile range.

###### 

Correlations(*r*) between methylation levels and histological parameters in NAFLD.

  Illumina ID (n=35)        Steatosis   Ballooning                                                  Inflammation   Fibrosis                                                                                                                                  
  ------------------------- ----------- ----------------------------------------------------------- -------------- ----------------------------------------------------------- -------- ----------------------------------------------------------- -------- -----------------------------------------------------------
  cg15653194 (LFNG)         −0.179      0.491                                                       −0.088         0.737                                                       0.485    0.049[\*](#tfn5-medscimonit-24-6946){ref-type="table-fn"}   −0.395   0.117
  cg00150500 (HCFC1R1)      −0.381      0.024[\*](#tfn5-medscimonit-24-6946){ref-type="table-fn"}   −0.337         0.048[\*](#tfn5-medscimonit-24-6946){ref-type="table-fn"}   −0.346   0.042[\*](#tfn5-medscimonit-24-6946){ref-type="table-fn"}   −0.179   0.303
  cg04787602 (*C1orf91*)    0.286       0.265                                                       0.382          0.131                                                       −0.522   0.032[\*](#tfn5-medscimonit-24-6946){ref-type="table-fn"}   0.355    0.161
  cg16398128 (ZNF622)       −0.119      0.495                                                       −0.031         0.859                                                       −0.497   0.002[\*](#tfn5-medscimonit-24-6946){ref-type="table-fn"}   −0.054   0.757
  cg07112456 (LRWD1)        −0.526      0.025[\*](#tfn5-medscimonit-24-6946){ref-type="table-fn"}   −0.439         0.069                                                       −0.132   0.448                                                       −0.095   0.708
  cg01693328 (not mapped)   0.164       0.346                                                       0.379          0.025[\*](#tfn5-medscimonit-24-6946){ref-type="table-fn"}   0.288    0.093                                                       0.21     0.226
  cg15226170 (PMM1)         −0.222      0.199                                                       0.032          0.854                                                       −0.369   0.029[\*](#tfn5-medscimonit-24-6946){ref-type="table-fn"}   −0.009   0.961
  cg08013262 (INSR)         0.145       0.406                                                       0.337          0.048[\*](#tfn5-medscimonit-24-6946){ref-type="table-fn"}   0.047    0.788                                                       0.083    0.635
  cg10178228 (FRMD4B)       −0.085      0.629                                                       0.048          0.785                                                       −0.2     0.249                                                       −0.062   0.723
  cg05131957 (CRLS1)        −0.445      0.007[\*](#tfn5-medscimonit-24-6946){ref-type="table-fn"}   −0.264         0.125                                                       −0.448   0.007[\*](#tfn5-medscimonit-24-6946){ref-type="table-fn"}   0.063    0.721
  cg19634213 (PTEN)         −0.358      0.035[\*](#tfn5-medscimonit-24-6946){ref-type="table-fn"}   −0.047         0.787                                                       −0.370   0.029[\*](#tfn5-medscimonit-24-6946){ref-type="table-fn"}   0.132    0.449
  cg12473838 (SSBP1)        −0.704      0.001[\*](#tfn5-medscimonit-24-6946){ref-type="table-fn"}   −0.542         0.001[\*](#tfn5-medscimonit-24-6946){ref-type="table-fn"}   −0.531   0.001[\*](#tfn5-medscimonit-24-6946){ref-type="table-fn"}   −0.219   0.001[\*](#tfn5-medscimonit-24-6946){ref-type="table-fn"}
  cg01067963 (MAPK1)        −0.343      0.044[\*](#tfn5-medscimonit-24-6946){ref-type="table-fn"}   −0.165         0.344                                                       −0.177   0.308                                                       −0.002   0.992
  cg22185268 (COMMD4)       −0.04       0.818                                                       0.187          0.283                                                       −0.341   0.045[\*](#tfn5-medscimonit-24-6946){ref-type="table-fn"}   0.066    0.706
  cg22721468 (SH3BP5L)      −0.19       0.275                                                       −0.122         0.484                                                       −0.337   0.048[\*](#tfn5-medscimonit-24-6946){ref-type="table-fn"}   −0.078   0.654
  cg13463639 (SIGIRR)       0.278       0.106                                                       0.321          0.059                                                       0.64     0.001[\*](#tfn5-medscimonit-24-6946){ref-type="table-fn"}   0.230    0.184
  cg13397649 (AFG3L2)       −0.375      0.138                                                       −0.543         0.024[\*](#tfn5-medscimonit-24-6946){ref-type="table-fn"}   0.093    0.722                                                       −0.286   0.267
  cg26309655 (TARS2)        0.294       0.252                                                       0.558          0.020[\*](#tfn5-medscimonit-24-6946){ref-type="table-fn"}   −0.399   0.113                                                       0.2      0.441
  cg04160753 (C10orf91)     −0.326      0.202                                                       0.078          0.766                                                       −0.486   0.048                                                       −0.157   0.549
  cg05102190 (ZYX)          −0.357      0.035[\*](#tfn5-medscimonit-24-6946){ref-type="table-fn"}   −0.197         0.256                                                       −0.362   0.033[\*](#tfn5-medscimonit-24-6946){ref-type="table-fn"}   −0.064   0.716
  cg00574958 (CTP1A)        0.134       0.441                                                       0.294          0.087                                                       0.443    0.008[\*](#tfn5-medscimonit-24-6946){ref-type="table-fn"}   0.232    0.180
  cg19878987 (LDHB)         −0.28       0.103                                                       −0.048         0.784                                                       −0.413   0.014[\*](#tfn5-medscimonit-24-6946){ref-type="table-fn"}   0.116    0.507
  cg15536552 (ACSL4)        0.482       0.050[\*](#tfn5-medscimonit-24-6946){ref-type="table-fn"}   0.316          0.216                                                       −0.385   0.127                                                       0.339    0.183

*p*\<0.05.

###### 

Comparison of the performance of each test for differentiating NASH versus simple hepatic steatosis.

  Test      AUC (95%CI)            Sig     Cut-off   Sens (%)   Spec (%)   PPV (%)   NPV (%)   *Z*-score   *P*-value
  --------- ---------------------- ------- --------- ---------- ---------- --------- --------- ----------- -----------
  CK18M65   0.733 (0.546--0.921)   0.027   756.35    73.3       75.0       78.6      76.5                  
  ACSL4     0.689 (0.556--0.821)   0.009   0.123     62.9       57.1       64.9      78.6      1.258       0.20
  CTP1A     0.745 (0.581--0.909)   0.013   0.151     70.6       72.2       70.6      72.2      0.08        0.93
  CRLS1     0.742 (0.578--0.906)   0.015   0.071     88.9       52.9       67.7      81.8      0.31        0.75
  SIGIRR    0.882 (0.758--0.999)   0.001   0.787     70.6       99         92.3      77.3      1.12        0.26
  SSBP1     0.817 (0.676--0.958)   0.001   0.04      61.1       94.1       91.7      69.6      0.32        0.75
  ZNF622    0.735 (0.567--0.903)   0.017   0.046     50.0       94.1       92.3      61.5      0.08        0.93

AUROC -- area under the receiver operating characteristic curve; Sens -- sensitivity; Spec -- specificity; PPV -- positive predictive value; NPV -- negative predictive value.
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